British scientists have developed a four-tier scoring style to await the death threat for patients hospitalized with COVID-19, saying they deserve to help doctors temporarily with the most productive care for each patient.
The tool, which is detailed in studies published Wednesday in the medical journal BMJ, is helping doctors locate patients in one of 4 COVID-19 threat teams: low, intermediate, maximum or very high death threat.
Visit our coronavirus here for the latest updates.
As hospitals around the world face waves of COVID-19 patients, the disease caused by the new coronavirus, doctors said they needed a faster and more accurate threat prediction team to temporarily identify patients with the highest death threat and receive specific treatment.
The new style, called coronavirus Clinical Characterization Consortium (4C), uses knowledge such as age, sex, underlying conditions, breathing and oxygen grades in the blood. should be of 15 comparable styles, the researchers said, and that was also more useful in clinical decision-making.
“This will help doctors optimally treat the sickest patients,” said Ewen Harrison, professor of surgery and knowledge science at the University of Edinburgh, who co-directed the studies and presented them at a briefing.
Using the other knowledge entries, the threat calculator provides scores ranging from 0 to 21 points, he said. Patients with a score of 15 or higher had a mortality threat of 62%, to 1% for those with a score of 3 or less. .
Researchers said patients with a low 4C mortality score may not want to be admitted to the hospital, while those on medium and high threat equipment can also accelerate for more competitive treatment, add steroids, and be admitted to intensive care. sets if necessary.
For all newer titles, stay on our Google News channel online or in the app.
Read more:
Coronavirus can spread intestinal infection, scientists say
Coronavirus: increasing in the formative years associated with COVID-19 type 1 diabetes in a new study
An aerosol chemical can kill coronavirus, SAYS UK study